{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-08-21", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "submissions": [ { "submission_type": "SUPPL", "submission_number": "29", "submission_status": "AP", "submission_status_date": "19990128", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "42772", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/062756_S029_PRIMAXIN.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "35", "submission_status": "AP", "submission_status_date": "20020419", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "42774", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/062756_S035_PRIMAXIN_ADD_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "27", "submission_status": "AP", "submission_status_date": "19961031", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "42771", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S027_PRIMAXIN I.V.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "41", "submission_status": "AP", "submission_status_date": "20040416", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "19", "submission_status": "AP", "submission_status_date": "19950712", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22281", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S011&S017&S019_PRIMAXIN", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "33", "submission_status": "AP", "submission_status_date": "20011011", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "42773", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S033&S034_PRIMAXIN_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "25", "submission_status": "AP", "submission_status_date": "19960508", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22285", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S025_PRIMAXIN I.V.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "17", "submission_status": "AP", "submission_status_date": "19950712", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "42766", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S011&S017&S019_PRIMAXIN", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "31", "submission_status": "AP", "submission_status_date": "20010831", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "8", "submission_status": "AP", "submission_status_date": "19931229", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "42765", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf", "date": "20070806", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "23", "submission_status": "AP", "submission_status_date": "19970430", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "42769", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/062756_S023_PRIMAXIN.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19870108" }, { "submission_type": "SUPPL", "submission_number": "15", "submission_status": "AP", "submission_status_date": "19920831", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22280", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S015_PRIMAXIN ADD-VANTAGE.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "6", "submission_status": "AP", "submission_status_date": "19910909", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22272", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S006_ADD_PRIMAXIN_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "21", "submission_status": "AP", "submission_status_date": "19950509", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "42768", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S021_PRIMAXIN ADD-VANTAGE.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "13", "submission_status": "AP", "submission_status_date": "19920218", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22278", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S013_PRIMAXIN ADD-VANTAGE.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "4", "submission_status": "AP", "submission_status_date": "19910226", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "42763", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S004_PRIMAXIN_ADD_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "58", "submission_status": "AP", "submission_status_date": "20170317", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "11", "submission_status": "AP", "submission_status_date": "19950712", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22276", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S011&S017&S019_PRIMAXIN", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "56", "submission_status": "AP", "submission_status_date": "20170402", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "46", "submission_status": "AP", "submission_status_date": "20100423", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "38", "submission_status": "AP", "submission_status_date": "20021017", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "42775", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/062756_S038_PRIMAXIN_ADD_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "28", "submission_status": "AP", "submission_status_date": "19980317", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22286", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/062756_S028_PRIMAXIN.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "34", "submission_status": "AP", "submission_status_date": "20011011", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22289", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S033&S034_PRIMAXIN_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "26", "submission_status": "AP", "submission_status_date": "19961011", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "42770", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S018&S022&S026_PRIMAXIN I.V.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "18", "submission_status": "AP", "submission_status_date": "19961011", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "42767", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S018&S022&S026_PRIMAXIN I.V.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "32", "submission_status": "AP", "submission_status_date": "20010910", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22288", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S032_PRIMAXIN_I.V._VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "9", "submission_status": "AP", "submission_status_date": "19910909", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22274", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S009_PRIMAXIN_ADD_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "24", "submission_status": "AP", "submission_status_date": "20010831", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22284", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/062756_S024_PRIMAXIN_ADD_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "30", "submission_status": "AP", "submission_status_date": "19991129", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22287", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/062756_S030_PRIMAXIN.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "7", "submission_status": "AP", "submission_status_date": "19931229", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22273", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf", "date": "20070806", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "22", "submission_status": "AP", "submission_status_date": "19961011", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22283", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/062756_S018&S022&S026_PRIMAXIN I.V.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "14", "submission_status": "AP", "submission_status_date": "19930203", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22279", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S014_PRIMAXIN ADD-VANTAGE.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "5", "submission_status": "AP", "submission_status_date": "19931229", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "42764", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf", "date": "20070806", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "20", "submission_status": "AP", "submission_status_date": "19940902", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22282", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S020_PRIMAXIN ADD-VANTAGE.pdf", "date": "20070913", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "12", "submission_status": "AP", "submission_status_date": "19920218", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)", "application_docs": [ { "id": "22277", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S012_PRIMAXIN ADD-VANTAGE.pdf", "date": "20070926", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "3", "submission_status": "AP", "submission_status_date": "19910307", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22271", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S003_PRIMAXIN_ADD_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "10", "submission_status": "AP", "submission_status_date": "19931229", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22275", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/062756_S005&S007&S008&S010_PRIMAXIN I.V.pdf", "date": "20070806", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "55", "submission_status": "AP", "submission_status_date": "20130628", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "39", "submission_status": "AP", "submission_status_date": "20040416", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "53", "submission_status": "AP", "submission_status_date": "20110228", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "45", "submission_status": "AP", "submission_status_date": "20060919", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" }, { "submission_type": "SUPPL", "submission_number": "37", "submission_status": "AP", "submission_status_date": "20020820", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "22290", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/062756_S037_PRIMAXIN_ADD_VANTAGE.pdf", "date": "20071119", "type": "Review" } ] }, { "submission_type": "SUPPL", "submission_number": "51", "submission_status": "AP", "submission_status_date": "20120508", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling" } ], "application_number": "ANDA062756", "sponsor_name": "MERCK", "products": [ { "product_number": "001", "reference_drug": "No", "brand_name": "PRIMAXIN", "active_ingredients": [ { "name": "CILASTATIN SODIUM", "strength": "EQ 250MG BASE/VIAL" }, { "name": "IMIPENEM", "strength": "250MG/VIAL" } ], "reference_standard": "No", "dosage_form": "INJECTABLE", "route": "INJECTION", "marketing_status": "Discontinued" }, { "product_number": "002", "reference_drug": "No", "brand_name": "PRIMAXIN", "active_ingredients": [ { "name": "CILASTATIN SODIUM", "strength": "EQ 500MG BASE/VIAL" }, { "name": "IMIPENEM", "strength": "500MG/VIAL" } ], "reference_standard": "No", "dosage_form": "INJECTABLE", "route": "INJECTION", "marketing_status": "Discontinued" } ] } ] }